Journal of Experimental & Clinical Cancer Research (Apr 2022)

Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

  • Maria Serena Roca,
  • Tania Moccia,
  • Federica Iannelli,
  • Cristina Testa,
  • Carlo Vitagliano,
  • Michele Minopoli,
  • Rosa Camerlingo,
  • Giulia De Riso,
  • Rossella De Cecio,
  • Francesca Bruzzese,
  • Mariarosaria Conte,
  • Lucia Altucci,
  • Elena Di Gennaro,
  • Antonio Avallone,
  • Alessandra Leone,
  • Alfredo Budillon

DOI
https://doi.org/10.1186/s13046-022-02324-2
Journal volume & issue
Vol. 41, no. 1
pp. 1 – 4

Abstract

Read online

No abstracts available.